BETHANY MALONE: Open Payments
NPI 1700338217 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 51 payments from 13 companies in 2025. Trend: 2023 $830 · 2024 $1,258 · 2025 $884
Food & beverage: $884
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $162 |
| Novo Nordisk Inc | 12 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $147 |
| Exact Sciences Corporation | 4 | $119 |
| Amgen Inc. | 6 | $97 |
| Abbott Laboratories | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: Kerendia, JARDIANCE, Cologuard Collection Kit, Ozempic, REPATHA, FREESTYLE LIBRE 3, Wegovy, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
